Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

FDA approves Lilly’s Onswik for type 2 diabetes in adults | PharmaVoice

Pharma Tech

FDA approves Lilly’s Onswik for type 2 diabetes in adults

Sep 25, 2026, 7:38 AM

Read Full Article → FDA approves Lilly’s Onswik for type 2 diabetes in adults

FDA approves Lilly’s Onswik for type 2 diabetes in adults

Translate article text

Choose a language and wait for the translated text.

The US FDA has approved Eli Lilly and Company’s Onswik, a once-weekly basal insulin injection for adults with type 2 diabetes.